• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4619882)   Today's Articles (186)   Subscriber (49404)
For: Clark RE, Ismail SA, Jacobs A, Payne H, Smith SA. A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome. Br J Haematol 1987;66:77-83. [PMID: 3297129 DOI: 10.1111/j.1365-2141.1987.tb06893.x] [Citation(s) in RCA: 71] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Number Cited by Other Article(s)
1
Smith FO, Dvorak CC, Braun BS. Myelodysplastic Syndromes and Myeloproliferative Neoplasms in Children. Hematology 2018. [DOI: 10.1016/b978-0-323-35762-3.00063-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]  Open
2
Danazol as First-Line Therapy for Myelodysplastic Syndrome. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 2017;18:e109-e113. [PMID: 29268959 DOI: 10.1016/j.clml.2017.11.007] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/01/2017] [Revised: 11/07/2017] [Accepted: 11/22/2017] [Indexed: 11/20/2022]
3
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood 2013;122:2943-64. [PMID: 23980065 DOI: 10.1182/blood-2013-03-492884] [Citation(s) in RCA: 478] [Impact Index Per Article: 43.5] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]  Open
4
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 2009;115:1850-7. [PMID: 20032503 PMCID: PMC2832815 DOI: 10.1182/blood-2009-10-249128] [Citation(s) in RCA: 149] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]  Open
5
Ria R, Moschetta M, Reale A, Mangialardi G, Castrovilli A, Vacca A, Dammacco F. Managing myelodysplastic symptoms in elderly patients. Clin Interv Aging 2009;4:413-23. [PMID: 19966910 PMCID: PMC2785865 DOI: 10.2147/cia.s5203] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2009] [Indexed: 11/23/2022]  Open
6
van der KERKHOF P, STEIJLEN P, RAYMAKERS R. Acrodermatitis continua of Hallopeau in a patient with myelodysplastic syndrome. Br J Dermatol 2008. [DOI: 10.1046/j.1365-2133.1996.90802.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
7
Visani G, Malagola M, Piccaluga PP, Isidori A. Low dose Ara-C for myelodysplastic syndromes: is it still a current therapy? Leuk Lymphoma 2004;45:1531-8. [PMID: 15370203 DOI: 10.1080/10428190310001653727] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
8
Kurzrock R. Myelodysplastic syndrome overview. Semin Hematol 2002;39:18-25. [PMID: 12214289 DOI: 10.1053/shem.2002.35981] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
9
Silverman LR, Demakos EP, Peterson BL, Kornblith AB, Holland JC, Odchimar-Reissig R, Stone RM, Nelson D, Powell BL, DeCastro CM, Ellerton J, Larson RA, Schiffer CA, Holland JF. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 2002;20:2429-40. [PMID: 12011120 DOI: 10.1200/jco.2002.04.117] [Citation(s) in RCA: 1334] [Impact Index Per Article: 60.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]  Open
10
Hofmann WOLFKARSTEN, Hoelzer DIETER. Malignancy: Current Clinical Practice: Current Therapeutic Options in Myelodysplastic Syndromes. HEMATOLOGY (AMSTERDAM, NETHERLANDS) 2001;4:91-112. [PMID: 11399556 DOI: 10.1080/10245332.1999.11746435] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
11
Saba HI. Myelodysplastic syndromes in the elderly. Cancer Control 2001;8:79-102. [PMID: 11176039 DOI: 10.1177/107327480100800112] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
12
Sadek I, Zayed E, Hayne O, Fernandez L. Prolonged complete remission of myelodysplastic syndrome treated with danazol, retinoic acid and low-dose prednisone. Am J Hematol 2000;64:306-10. [PMID: 10911385 DOI: 10.1002/1096-8652(200008)64:4<306::aid-ajh12>3.0.co;2-v] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
13
Dutcher JP, Wiernik PH. Novel biologic approaches to hematologic malignancies. Cancer Treat Res 1999;99:275-306. [PMID: 9891872 DOI: 10.1007/978-0-585-38571-6_12] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
14
Beran M, Estey E, O'Brien SM, Giles FJ, Koller CA, Kornblau S, Keating M, Kantarjian HM. Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 1998;31:521-31. [PMID: 9922042 DOI: 10.3109/10428199809057611] [Citation(s) in RCA: 57] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
15
Santini V, Ferrini PR. Differentiation therapy of myelodysplastic syndromes: fact or fiction? Br J Haematol 1998;102:1124-38. [PMID: 9753034 DOI: 10.1046/j.1365-2141.1998.00881.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
16
List AF. Hematopoietic stimulation by amifostine and sodium phenylbutyrate: what is the potential in MDS? Leuk Res 1998;22 Suppl 1:S7-11. [PMID: 9734693 DOI: 10.1016/s0145-2126(98)00034-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
17
Nair R, Nair CN, Advani SH. All trans retinoic acid with low dose cytosine arabinoside in the treatment of myelodysplastic syndrome. Leuk Lymphoma 1998;29:187-92. [PMID: 9638988 DOI: 10.3109/10428199809058394] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
18
Modulation of Idarubicin-Induced Apoptosis in Human Acute Myeloid Leukemia Blasts by All-Trans Retinoic Acid, 1,25(OH)2 Vitamin D3, and Granulocyte-Macrophage Colony-Stimulating Factor. Blood 1997. [DOI: 10.1182/blood.v90.11.4578] [Citation(s) in RCA: 59] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
19
Modulation of Idarubicin-Induced Apoptosis in Human Acute Myeloid Leukemia Blasts by All-Trans Retinoic Acid, 1,25(OH)2 Vitamin D3, and Granulocyte-Macrophage Colony-Stimulating Factor. Blood 1997. [DOI: 10.1182/blood.v90.11.4578.4578_4578_4587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
20
The Myelodysplastic Syndromes. Oncologist 1997. [DOI: 10.1634/theoncologist.2-1-28] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
21
Schmetzer HM, Rapp L, Wilmanns W, Gerhartz HH. Effect of GM-CSF, 1, 25-Dihydroxycholecalciferol (Vit.D) and All-Trans-Retinoic Acid (ATRA) on the Proliferation and Differentiation of MDS-Bone Marrow (BM)-Cells In Vitro. Hematology 1997;2:11-9. [PMID: 27406722 DOI: 10.1080/10245332.1997.11746315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]  Open
22
Scott RE. Differentiation, differentiation/gene therapy and cancer. Pharmacol Ther 1997;73:51-65. [PMID: 9014206 DOI: 10.1016/s0163-7258(96)00120-9] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
23
Ferrero D, Bruno B, Pregno P, Stefani S, Larizza E, Ciravegna G, Luraschi A, Vietti-Ramus G, Schinco P, Bazzan M, Gallo E, Pileri A. Combined differentiating therapy for myelodysplastic syndromes: a phase II study. Leuk Res 1996;20:867-76. [PMID: 8960111 DOI: 10.1016/0145-2126(95)00156-5] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
24
San Miguel JF, Sanz GF, Vallespí T, del Cañizo MC, Sanz MA. Myelodysplastic syndromes. Crit Rev Oncol Hematol 1996;23:57-93. [PMID: 8817082 DOI: 10.1016/1040-8428(96)00197-7] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]  Open
25
Economopoulos T, Papageorgiou E, Stathakis N, Constantinidou M, Parharidou A, Kostourou A, Dervenoulas J, Raptis S. Treatment of high risk myelodysplastic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor. (GM-CSF). Leuk Res 1996;20:385-90. [PMID: 8683977 DOI: 10.1016/0145-2126(95)00169-7] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
26
KERKHOF P, STEIJLEN P, RAYMAKERS R. Acrodermatitis continua of Hallopeau in a patient with myelodysplastic syndrome. Br J Dermatol 1996. [DOI: 10.1111/j.1365-2133.1996.tb06985.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
27
Saba HI. Myelodysplastic syndromes in the elderly: the role of growth factors in management. Leuk Res 1996;20:203-19. [PMID: 8637215 DOI: 10.1016/0145-2126(95)00131-x] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
28
Schultz AB, Geller RB, Hillyer CD. The role of bone marrow transplantation in the treatment of myelodysplastic syndromes. JOURNAL OF HEMATOTHERAPY 1995;4:323-34. [PMID: 7489147 DOI: 10.1089/scd.1.1995.4.323] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
29
Porter SR, Scully C. Gingival and oral mucosal ulceration associated with the myelodysplastic syndrome. EUROPEAN JOURNAL OF CANCER. PART B, ORAL ONCOLOGY 1994;30B:346-50. [PMID: 7703805 DOI: 10.1016/0964-1955(94)90037-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
30
Ohno R. Differentiation therapy of myelodysplastic syndromes with retinoic acid. Leuk Lymphoma 1994;14:401-9. [PMID: 7812199 DOI: 10.3109/10428199409049696] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
31
De Witte T. New treatment approaches for myelodysplastic syndrome and secondary leukaemias. Ann Oncol 1994;5:401-8. [PMID: 8075047 DOI: 10.1093/oxfordjournals.annonc.a058870] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]  Open
32
McCarley DL. New uses for old vitamins. The treatment of myelodysplastic disorders. Med Clin North Am 1993;77:919-29. [PMID: 8321079 DOI: 10.1016/s0025-7125(16)30234-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
33
Treatment of Therapy-Related Acute Myelogenous Leukemia and Myelodysplastic Syndromes. Hematol Oncol Clin North Am 1993. [DOI: 10.1016/s0889-8588(18)30253-3] [Citation(s) in RCA: 25] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
34
Kantarjian HM, Estey EH, Keating MJ. Treatment of Therapy-Related Leukemia and Myelodysplastic Syndrome. Hematol Oncol Clin North Am 1993. [DOI: 10.1016/s0889-8588(18)30259-4] [Citation(s) in RCA: 58] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
35
Tallman MS, Wiernik PH. Retinoids in cancer treatment. J Clin Pharmacol 1992;32:868-88. [PMID: 1447394 DOI: 10.1002/j.1552-4604.1992.tb04633.x] [Citation(s) in RCA: 49] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
36
Economopoulos T, Papageorgiou E, Stathakis N, Asprou N, Karmas P, Dervenoulas J, Bouronikou H, Chalevelakis G, Raptis S. Treatment of myelodysplastic syndromes with human granulocytic-macrophage colony stimulating factor (GM-CSF) or GM-CSF combined with low-dose cytosine arabinoside. Eur J Haematol 1992;49:138-42. [PMID: 1446728 DOI: 10.1111/j.1600-0609.1992.tb00918.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
37
Hayani A, Mahoney DH, Taylor LD. Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy. J Neurooncol 1992;14:57-62. [PMID: 1469465 DOI: 10.1007/bf00170945] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
38
Paquette RL, Koeffler HP. Differentiation Therapy. Hematol Oncol Clin North Am 1992. [DOI: 10.1016/s0889-8588(18)30336-8] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
39
Noël P, Solberg LA. Myelodysplastic syndromes. Pathogenesis, diagnosis and treatment. Crit Rev Oncol Hematol 1992;12:193-215. [PMID: 1379818 DOI: 10.1016/1040-8428(92)90054-t] [Citation(s) in RCA: 28] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]  Open
40
Besa EC. Myelodysplastic syndromes (refractory anemia). A perspective of the biologic, clinical, and therapeutic issues. Med Clin North Am 1992;76:599-617. [PMID: 1578959 DOI: 10.1016/s0025-7125(16)30342-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
41
Aul C, Gattermann N. The role of low-dose chemotherapy in myelodysplastic syndromes. Leuk Res 1992;16:207-15. [PMID: 1560670 DOI: 10.1016/0145-2126(92)90058-f] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
42
Gerhartz HH, Marcus R, Delmer A, Zwierzina H, de Witte T, Jacobs A, Visiani G, Fiere D, Sonneveld P, Labar B. Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF). The EORTC Leukaemia Group. Infection 1992;20 Suppl 2:S116-23. [PMID: 1493935 DOI: 10.1007/bf01705030] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
43
De Rosa L, Montuoro A, De Laurenzi A. Therapy of 'high risk' myelodysplastic syndromes with an association of low-dose Ara-C, retinoic acid and 1,25-dihydroxyvitamin D3. Biomed Pharmacother 1992;46:211-7. [PMID: 1467449 DOI: 10.1016/0753-3322(92)90084-k] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]  Open
44
Hast R, Hellström E. Therapeutic aspects of myelodysplastic syndromes in chronic phase. Leuk Res 1992;16:95-100. [PMID: 1310127 DOI: 10.1016/0145-2126(92)90107-i] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
45
Noël P. Management of patients with myelodysplastic syndromes. Mayo Clin Proc 1991;66:485-97. [PMID: 2030615 DOI: 10.1016/s0025-6196(12)62389-1] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
46
Bruetman DG, Harris JE, Anderson KM. Differentiating agents in malignant disease. MEDICAL AND PEDIATRIC ONCOLOGY 1991;19:71-83. [PMID: 2011099 DOI: 10.1002/mpo.2950190202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
47
Chomienne C. Low-dose chemotherapy and differentiating agents. BAILLIERE'S CLINICAL HAEMATOLOGY 1991;4:47-68. [PMID: 2039861 DOI: 10.1016/s0950-3536(05)80284-7] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
48
Besa EC, Abrahm JL, Bartholomew MJ, Hyzinski M, Nowell PC. Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol. Am J Med 1990;89:739-47. [PMID: 2252043 DOI: 10.1016/0002-9343(90)90215-y] [Citation(s) in RCA: 49] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
49
Hellström E, Robèrt KH, Samuelsson J, Lindemalm C, Grimfors G, Kimby E, Oberg G, Winqvist I, Billström R, Carneskog J. Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study. The Scandinavian Myelodysplasia Group (SMG). Eur J Haematol 1990;45:255-61. [PMID: 2261951 DOI: 10.1111/j.1600-0609.1990.tb00470.x] [Citation(s) in RCA: 46] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
50
De Witte T, Muus P, De Pauw B, Haanen C. Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia. Cancer 1990;66:831-7. [PMID: 2386911 DOI: 10.1002/1097-0142(19900901)66:5<831::aid-cncr2820660503>3.0.co;2-e] [Citation(s) in RCA: 77] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
PrevPage 1 of 2 12Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA